title: Dengue virus infection: current concepts in immune mechanisms and lessons from murine models.
abstract: Dengue viruses (DENV), a group of four serologically distinct but related flaviviruses, are responsible for one of the most important emerging viral diseases. This mosquito-borne disease has a great impact in tropical and subtropical areas of the world in terms of illness, mortality and economic costs, mainly due to the lack of approved vaccine or antiviral drugs. Infections with one of the four serotypes of DENV (DENV-1-4) result in symptoms ranging from an acute, self-limiting febrile illness, dengue fever, to severe dengue haemorrhagic fever or dengue shock syndrome. We reviewed the existing mouse models of infection, including the DENV-2-adapted strain P23085. The role of CC chemokines, interleukin-17 (IL-17), IL-22 and invariant natural killer T cells in mediating the exacerbation of disease in immune-competent mice is highlighted. Investigations in both immune-deficient and immune-competent mouse models of DENV infection may help to identify key host–pathogen factors and devise novel therapies to restrain the systemic and local inflammatory responses associated with severe DENV infection.
authors.forename: Rodrigo
authors.initials: R
authors.lastname: Guabiraba
authors.forename: Bernhard
authors.initials: B
authors.lastname: Ryffel
mesh_terms: D000818:Animals; D001792:Blood Platelets / Q000502:physiology; D019742:Chemokines, CC / Q000276:immunology; D003715:Dengue / Q000276:immunology*; D004195:Disease Models, Animal; D006801:Humans; D016867:Immunocompromised Host; D020381:Interleukin-17 / Q000276:immunology; D007378:Interleukins / Q000276:immunology; D051379:Mice; D055611:Natural Killer T-Cells / Q000276:immunology; D058504:Th17 Cells / Q000276:immunology; D000097043:Interleukin-22
chemical_list: D019742:Chemokines, CC; D020381:Interleukin-17; D007378:Interleukins; D000097043:Interleukin-22